
TY  - JOUR
TI  - ORTHOPAEDIC SURGERY AND SPORTS MEDICINE
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_18.x
DO  - doi:10.1111/j.1479-8077.2006.00199_18.x
SP  - A101
EP  - A108
PY  - 2006
ER  - 

TY  - JOUR
TI  - RHEUMATOID ARTHRITIS – CLINICAL ASPECTS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_23.x
DO  - doi:10.1111/j.1479-8077.2006.00199_23.x
SP  - A167
EP  - A188
PY  - 2006
ER  - 

TY  - JOUR
AU  - Facciorusso, Antonio
AU  - Del Prete, Valentina
AU  - Muscatiello, Nicola
AU  - Crucinio, Nicola
AU  - Barone, Michele
C8  - JGH-00021-2016.R1
TI  - Prognostic role of 25-hydroxyvitamin D in patients with liver metastases from colorectal cancer treated with radiofrequency ablation
JO  - Journal of Gastroenterology and Hepatology
JA  - Journal of Gastroenterology and Hepatology
VL  - 31
IS  - 8
SN  - 0815-9319
UR  - https://doi.org/10.1111/jgh.13326
DO  - doi:10.1111/jgh.13326
SP  - 1483
EP  - 1488
KW  - colorectal liver metastases
KW  - radiofrequency ablation
KW  - survival
KW  - vitamin D
PY  - 2016
AB  - Abstract Background and Aim Vitamin D is implicated in the etiology of several neoplastic diseases, but its relationship with colorectal cancer survival is still unclear. Aim of this study was to determine whether vitamin D levels influence survival outcomes in colorectal cancer liver metastases patients treated with percutaneous radiofrequency ablation. Methods We measured 25-hydroxyvitamin D levels in 143 patients with 215 colorectal liver metastases who underwent radiofrequency ablation between 1999 and 2011 at our institution. The influence of 25-hydroxyvitamin D levels on overall survival and time to recurrence was evaluated in univariate and multivariate Cox analyses. Results Median age was 68?years (range 41?85), and median number of nodules was 2 (1?3) with a median maximum diameter of 26?mm (10?48). Median survival was 44?months (36?62), and survival rate was 91.4%, 46.5%, and 42.2% at 1, 4, and 5?years in the whole cohort. Median survival was 65?months (52?74) if 25-hydroxyvitamin D?>20?ng/mL and 34?months (24?41) if?≤20?ng/mL (P?<?0.001). In the whole cohort, median time to recurrence was 34?months (26?47), 50?months (36?62) in the case of 25-hydroxyvitamin D?>20?ng/mL and 24?months (20?32) if?≤20?ng/mL (P?<?0.001). Nodule size and 25-hydroxyvitamin D resulted as significant predictors of both overall survival and time to recurrence in multivariate analysis. Conclusions Our study provides support for the use of 25-hydroxyvitamin D as a new predictor of outcome for colorectal liver metastases patients.
ER  - 

TY  - JOUR
TI  - Special Report: Selected Nutrition Practice Poster Abstracts
JO  - Nutrition in Clinical Practice
JA  - Nutrition in Clinical Practice
VL  - 13
IS  - 2
SN  - 0884-5336
UR  - https://doi.org/10.1177/088453369801300214
DO  - doi:10.1177/088453369801300214
SP  - 97
EP  - 104
PY  - 1998
ER  - 

TY  - JOUR
TI  - 55th Annual Scientific Meeting of the Royal Australian and New Zealand College of Radiologists, 21–24 October 2004, Perth, Western Australia
JO  - Australasian Radiology
VL  - 49
IS  - 3
SN  - 0004-8461
UR  - https://doi.org/10.1111/j.1440-1673.2005.01464.x
DO  - doi:10.1111/j.1440-1673.2005.01464.x
SP  - A7
EP  - A36
PY  - 2005
ER  - 

TY  - JOUR
TI  - Poster Presentation Abstracts
JO  - International Journal of Laboratory Hematology
JA  - Int. Jnl. Lab. Hem.
VL  - 36
IS  - s1
SN  - 1751-5521
UR  - https://doi.org/10.1111/ijlh.12266
DO  - doi:10.1111/ijlh.12266
SP  - 30
EP  - 131
PY  - 2014
ER  - 

TY  - JOUR
TI  - GENOMICS, GENETIC BASIS OF DISEASE AND HLA/T CELL RECOGNITION
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_11.x
DO  - doi:10.1111/j.1479-8077.2006.00199_11.x
SP  - A66
EP  - A68
PY  - 2006
ER  - 

TY  - JOUR
TI  - INFECTION-RELATED RHEUMATIC DISEASES
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_14.x
DO  - doi:10.1111/j.1479-8077.2006.00199_14.x
SP  - A80
EP  - A83
PY  - 2006
ER  - 

TY  - JOUR
TI  - MISCELLANEOUS RHEUMATIC DISEASES
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_16.x
DO  - doi:10.1111/j.1479-8077.2006.00199_16.x
SP  - A90
EP  - A99
PY  - 2006
ER  - 

TY  - JOUR
TI  - OSTEOPOROSIS – CLINICAL ASPECTS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_20.x
DO  - doi:10.1111/j.1479-8077.2006.00199_20.x
SP  - A125
EP  - A142
PY  - 2006
ER  - 

TY  - JOUR
TI  - SPONDYLOARTHROPATHIES INCLUDING PSORIATIC ARTHRITIS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_28.x
DO  - doi:10.1111/j.1479-8077.2006.00199_28.x
SP  - A234
EP  - A247
PY  - 2006
ER  - 

TY  - JOUR
TI  - BACK PAIN
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_3.x
DO  - doi:10.1111/j.1479-8077.2006.00199_3.x
SP  - A26
EP  - A31
PY  - 2006
ER  - 

TY  - JOUR
TI  - BONE DISEASES OTHER THAN OSTEOPOROSIS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_4.x
DO  - doi:10.1111/j.1479-8077.2006.00199_4.x
SP  - A31
EP  - A33
PY  - 2006
ER  - 

TY  - JOUR
TI  - SYSTEMIC LUPUS ERYTHEMATOSUS – AETIOLOGY AND PATHOGENESIS/ANIMAL MODELS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_29.x
DO  - doi:10.1111/j.1479-8077.2006.00199_29.x
SP  - A247
EP  - A253
PY  - 2006
ER  - 

TY  - JOUR
TI  - CARTILAGE IN BONE BIOLOGY AND PATHOPHYSIOLOGY
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_5.x
DO  - doi:10.1111/j.1479-8077.2006.00199_5.x
SP  - A33
EP  - A39
PY  - 2006
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Vox Sanguinis
JA  - Vox Sang
VL  - 109
IS  - S2
SN  - 0042-9007
UR  - https://doi.org/10.1111/vox.12359
DO  - doi:10.1111/vox.12359
SP  - 1
EP  - 96
PY  - 2015
ER  - 

TY  - JOUR
TI  - Program & Abstracts
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 17
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.5650170102
DO  - doi:10.1002/jbmr.5650170102
SP  - S1
EP  - S502
PY  - 2002
ER  - 

TY  - JOUR
TI  - METABOLIC AND CRYSTAL ARTHROPATHIES
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_15.x
DO  - doi:10.1111/j.1479-8077.2006.00199_15.x
SP  - A83
EP  - A90
PY  - 2006
ER  - 

TY  - JOUR
TI  - OSTEOARTHRITIS – CLINICAL ASPECTS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_19.x
DO  - doi:10.1111/j.1479-8077.2006.00199_19.x
SP  - A108
EP  - A125
PY  - 2006
ER  - 

TY  - JOUR
TI  - ANTI-PHOSPHOLIPID SYNDROME
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_2.x
DO  - doi:10.1111/j.1479-8077.2006.00199_2.x
SP  - A25
EP  - A26
PY  - 2006
ER  - 
